Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Chong Kun Dang Pharmaceutical

55 clinical trials

Clinical trial
A Phase 1, First-in-Human, Double-blind, Randomized, Placebo Controlled Study to Assess the Safety, Tolerability, PK and PD and Food Effect of CKD-508 After Single and Multiple Ascending Oral Dose Administration in Healthy Adult Subjects
Status: Completed, Estimated PCD: 2023-07-02
Clinical trial
A Phase I Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic Characteristics After Administration of D958 and CKD-341 in Healthy Adult Volunteers
Status: Completed, Estimated PCD: 2023-09-01
Clinical trial
A Phase I Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic Characteristics After Administration of CKD-391(2) and Co-administration of CKD-331 and D337 in Healthy Adult Volunteers
Status: Completed, Estimated PCD: 2024-01-07
Clinical trial
An Open Label, Randomized, Single Dose, 2-sequence, 4-period, Cross-over Clinical Trial to Evaluate the Pharmacokinetics and Tolerability of CKD-348(2) With Coadministration of CKD-828, D097 and D337 in Healthy Adult Volunteers
Status: Completed, Estimated PCD: 2021-07-20
Clinical trial
An Open Label, Randomized, Single Dose, 2-sequence, 4-period, Cross-over Clinical Trial to Evaluate the Pharmacokinetics and Tolerability of CKD-348 With Coadministration of CKD-828, D097 and D337 in Healthy Adult Volunteers
Status: Completed, Estimated PCD: 2021-02-24
Clinical trial
A Randomized, Open-label, Single Oral Dosing, Two-sequence, and Two-period Crossover Study to Evaluate the Pharmacokinetics and Safety Between Administration of CKD-383 and Co-administration of CKD-501, D745, D150, and D029
Status: Completed, Estimated PCD: 2023-07-23
Clinical trial
A Randomized, Open-label, Single Dose, 4-period Replicate Crossover Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-341 in Healthy Volunteers Under Fasting Conditions
Status: Active (not recruiting), Estimated PCD: 2024-05-07
Clinical trial
A Phase I Clinical Trial to Evaluate the Tolerability and the Pharmacokinetics of CKD-348(6) Compared With Co-administration of CKD-828, D097, and D337 in Healthy Adult Volunteers
Status: Completed, Estimated PCD: 2024-02-19
Clinical trial
A Randomized, Open-label, Multiple-dose and Parallel Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of CKD-843 A in Male Subjects
Status: Completed, Estimated PCD: 2023-09-15
Clinical trial
A Randomized, Open-label, Single-dose, Two-way Crossover Clinical Trial to Investigate the Pharmacokinetics and Safety After Oral Administration of CKD-378 and Co-administration of D745, D150, D029 in Healthy Adults
Status: Completed, Estimated PCD: 2023-06-28
Clinical trial
A Randomized, Open-label, Single Dose, Crossover, Phase Ⅰ Trial to Evaluate the Food Effect on Pharmacokinetic Profiles and Safety of CKD-379 in Healthy Volunteers
Status: Completed, Estimated PCD: 2023-12-06
Clinical trial
A Randomized, Open-label, Single-dosing, 3-treatment, 6-sequence, 3-period, Crossover-design Pilot Clinical Trial to Compare the Safety and Pharmacokinetics of D113 With CKD-349 in Healthy Adult Volunteers
Status: Completed, Estimated PCD: 2021-07-29
Clinical trial
A Randomized, Double-blind, Multi-center, Therapeutic Confirmatory, Phase 3 Trial To Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy Versus D064 or D702 Monotherapy in Essential Hypertension Patients
Status: Completed, Estimated PCD: 2024-03-22
Clinical trial
A Phase I Clinical Trial to Evaluate the Tolerability and the Pharmacokinetics of CKD-348(5) Compared With Co-administration of CKD-828, D097, and D337 in Healthy Adult Volunteers
Status: Completed, Estimated PCD: 2023-06-07
Clinical trial
A Randomized, Open-label, Single Oral Dosing, Two-sequence, and Two-period Crossover Study to Evaluate the Pharmacokinetics and Safety Between the Administration of CKD-383 and the Co-administration of CKD-501, D744, and D150 for Healthy Subjects in Fed State
Status: Completed, Estimated PCD: 2023-06-04
Clinical trial
A Randomized, Open-label, Single-dose, Two-way Crossover Clinical Trial to Investigate the Pharmacokinetics and Safety After Oral Administration of CKD-378 and Co-administration of D745, D150 in Healthy Adults
Status: Completed, Estimated PCD: 2023-08-31
Clinical trial
An Open-label, Randomized, Single-dose, 2-sequence, 2-period, Crossover, Phase 1 Study to Evaluate the Food Effect on the Pharmacokinetics and Safety of CKD-378 in Healthy Volunteers
Status: Not yet recruiting, Estimated PCD: 2024-06-03
Clinical trial
An Open-label, Randomized, Multiple-dose, Three-way Crossover Study to Compare the Pharmacokinetic Characteristics and Safety Among D745, D759, and D150 in Healthy Subjects
Status: Completed, Estimated PCD: 2023-08-29
Clinical trial
An Open Label, Randomized, Single Dose, 2-sequence, 4-period, Cross-over Clinical Trial to Evaluate the Pharmacokinetics and Tolerability of CKD-386(3) With Co-administration of D013, D326, and D337 in Healthy Adult Volunteers
Status: Completed, Estimated PCD: 2022-06-06
Clinical trial
A Randomized, Double-blind, Multi-center, Therapeutic Confirmatory, Phase 3 Trial To Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy Versus D660 Monotherapy in Essential Hypertension Patients
Status: Recruiting, Estimated PCD: 2023-08-23
Clinical trial
A Randomized, Open-label, Single Dose, 3-period, 6-treatment, Crossover Study to Compare the Pharmacokinetics and Safety/Tolerability of CKD-379 and Coadministration of D759, D745 and D150 in Healthy Subjects
Status: Completed, Estimated PCD: 2022-08-27
Clinical trial
An Open-label, Randomized, Fasted, Single-dose, Three-way Crossover Study to Compare the Pharmacokinetic Characteristics and Safety Between Administration of CKD-828 and Administration of D064,D701 in Healthy Adults
Status: Completed, Estimated PCD: 2022-11-15
Clinical trial
An Open-label, Randomized, Fasted, Single-dose, Three-way Crossover Study to Compare the Pharmacokinetic Characteristics and Safety Between Administration of CKD-341 and Administration of D958 in Healthy Adults
Status: Completed, Estimated PCD: 2022-12-04
Clinical trial
A Multicenter, Randomized, Single Blind, Single Dose, Crossover Study to Evaluate the Pharmacokinetic Profiles and Safety After Administration of CKD-845 in Males
Status: Completed, Estimated PCD: 2022-05-17
Clinical trial
An Open Label, Randomized, Single Dose Crossover Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD 371 in Healthy Subjects
Status: Completed, Estimated PCD: 2022-11-14
Clinical trial
A Phase I Clinical Trial to Evaluate the Tolerability and the Pharmacokinetics of CKD-348 With Co-administration of CKD-828, D097, and D337 in Healthy Adult Volunteers
Status: Completed, Estimated PCD: 2022-11-30
Clinical trial
A Phase 2, Randomized, Double-blind, Multi-center, Parallel-group Trial to Evaluate the Efficacy and Safety of CKD-498 in Female Patients With Androgenetic Alopecia
Status: Recruiting, Estimated PCD: 2024-04-30
Clinical trial
A Randomized, Open-label, Single Dose, Crossover Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-393 in Healthy Volunteers Under Fed Conditions
Status: Completed, Estimated PCD: 2021-12-06
Clinical trial
An Open-label, Randomized, Fasted, Single-dose, 2-sequence, 4-period, Replicate Crossover Study to Compare the Pharmacokinetic and Safety Between Administration of CKD-828 20/2.5mg and Administration of D064, D701 in Healthy Adults
Status: Completed, Estimated PCD: 2023-07-18
Clinical trial
A Phase I Clinical Trial to Evaluate the Tolerability and the Pharmacokinetics of CKD-386 With Co-administration of D013, D326, and D337 in Healthy Adult Volunteers
Status: Completed, Estimated PCD: 2022-11-27
Clinical trial
An Open-label, Randomized, Single-dose, 2-sequence, 4-period, Cross-over, Phase 1 Study to Evaluate the Safety and Pharmacokinetics of CKD-331 in Healthy Adult Volunteers
Status: Completed, Estimated PCD: 2022-06-23
Clinical trial
An Open Label, Randomized, Single Dose, 2-sequence, 4-period, Cross-over Clinical Trial to Evaluate the Pharmacokinetics and Tolerability of CKD-348(3) With Coadministration of CKD-828, D097 and D337 in Healthy Adult Volunteers
Status: Completed, Estimated PCD: 2022-05-08
Clinical trial
An Open Label, Randomized, Single-dose, 2-sequence, 2-period, Cross-over Phase 1 Study to Evaluate the Safety and Pharmacokinetics of CKD-349 in Healthy Adult Volunteers
Status: Completed, Estimated PCD: 2022-01-18
Clinical trial
A Randomized, Open-label, Single Dose, 4-period Replicate Crossover Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-828 in Healthy Volunteers Under Fasting Conditions
Status: Completed, Estimated PCD: 2023-09-02
Clinical trial
A Randomized, Open-label, Single Dose, Crossover Study to Evaluate the Food Effect on Pharmacokinetic Profiles and Safety of CKD-393 in Healthy Volunteers
Status: Completed, Estimated PCD: 2022-07-15
Clinical trial
A Multi-center, Randomized, Open-label, Active Comparator-controlled, Phase 4 Clinical Trial to Evaluate the Blood Pressure Control of Telmisartan or Losartan in Essential Hypertensive Patients With Metabolic Syndrome
Status: Not yet recruiting, Estimated PCD: 2023-12-31
Clinical trial
A Randomized, Open-label, 2-period, Parallel Group, Multiple-dose Phase 1 Study to Evaluate Drug-drug Interaction, Safety and Tolerability in Case of the Co-administration of D565 and D930, in Healthy Male Subjects
Status: Completed, Estimated PCD: 2022-10-18
Clinical trial
An Open Label, Randomized, Single Dose, 2-sequence, 4-period, Cross-over Clinical Trial to Evaluate the Pharmacokinetics and the Tolerability of CKD-386(5) With Co-administration of D013, D326, and D337 in Healthy Adult Volunteers
Status: Completed, Estimated PCD: 2023-09-01
Clinical trial
A Randomized, Open-label and Parallel Study to Evaluate the Pharmacokinetics and Safety of CKD-846 in Healthy Male Subjects
Status: Not yet recruiting, Estimated PCD: 2024-01-16
Clinical trial
A Multicenter, Randomization, Open-label Phase 4 Clinical Trial to Evaluate the Efficacy and Safety of MYREPTIC-N® or MY-REPT® in Stable Patients After Kidney Transplant Recipients
Status: Not yet recruiting, Estimated PCD: 2025-09-01
Clinical trial
A Phase I Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic Characteristics After Administration of CKD-391 and Co-administration of CKD-331 and D337 in Healthy Adult Volunteers
Status: Completed, Estimated PCD: 2023-02-27
Clinical trial
A Randomized, Open-label, Single Dose, 2-period, 2-treatment, Crossover Study to Compare the Pharmacokinetics and Safety/Tolerability of CKD-379 and Coadministration of D759, D745 and D150 in Healthy Subjects
Status: Completed, Estimated PCD: 2023-03-23
Clinical trial
An Open-label, Randomized, Single-dose Crossover Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-388 in Healthy Subjects
Status: Completed, Estimated PCD: 2022-03-12
Clinical trial
A Randomized, Open-Label, Crossover Study to Evaluate the Relative Bioavailability of a Tablet Formulation of CKD-510 as Compared to Capsule and to Assess the Effect of Food on the CKD 510 Tablet Formulation in Healthy Subjects
Status: Completed, Estimated PCD: 2022-09-13
Clinical trial
A Randomized, Double-blind, Multi-center, Therapeutic Confirmatory, Phase 3 Trial to Evaluate the Efficacy and Safety of D150, D745 and D759 Combination Therapy in Pateints With Type 2 Diabetes Inadequately Controlled With D150 Plus D759
Status: Recruiting, Estimated PCD: 2024-04-16
Clinical trial
A Randomized, Double-blind, Multi-center, Therapeutic Confirmatory, Phase 3 Trial to Evaluate the Efficacy and Safety of CKD-391 and CKD-331 in Patients With Primary Hypercholesterolemia
Status: Recruiting, Estimated PCD: 2023-06-01
Clinical trial
A Randomized, Double-blind, Multi-center, Therapeutic Confirmatory, Phase 3 Trial To Evaluate the Efficacy and Safety of D064 and D701 Combination Therapy in Essential Hypertension Subjects Inadequately Controlled by D064 Monotherapy
Status: Recruiting, Estimated PCD: 2023-10-01
Clinical trial
A Randomized, Open-label, Single Dose, Crossover Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-379 in Healthy Volunteers Under Fed Conditions
Status: Active (not recruiting), Estimated PCD: 2023-06-19
Clinical trial
A Randomized, Open-label, Single Dose, Crossover Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-387 in Healthy Volunteers Under Fasting Conditions
Status: Completed, Estimated PCD: 2022-09-26
Clinical trial
A Randomized, Open-label, Single Dose, Crossover Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-387 in Healthy Volunteers Under Fed Conditions
Status: Completed, Estimated PCD: 2022-09-29
Clinical trial
A Randomized, Open-label, Single Dose, Crossover Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-387 in Healthy Volunteers Under Fasting Condition
Status: Completed, Estimated PCD: 2023-02-11
Clinical trial
The Role of an EsoDuo® to Control Reflux Symptoms Related to the Acid; a Multicenter, Open-labeled, Phase 4 Study [RACER Study]
Status: Recruiting, Estimated PCD: 2025-01-01
Clinical trial
A Multi-center, Randomized, Open-label, Active Comparator-controlled, Phase 4 Clinical Trial To Evaluate the Efficacy and Safety of Telmisartan Compared With Losartan in Patients With Diabetic Nephropathy and Hypertension
Status: Recruiting, Estimated PCD: 2025-10-31
Clinical trial
Impact of Lymphocyte Anti-metabolite Immunosuppressions on Donor-Specific Anti-HLA Antibody and Kidney Graft Outcome: Open-label, Multi-center, Single Arm, Phase 4 Trial (DoSAKOM)
Status: Completed, Estimated PCD: 2022-07-22
Clinical trial
A Randomized, Open-label, Single Oral Dosing, Two-sequence, and Two-period Crossover Study to Evaluate the Pharmacokinetics and Safety Between the Administration of CKD-383 and the Co-administration of CKD-501, D745, and D150 for Healthy Subjects in Fed State
Status: Completed, Estimated PCD: 2024-04-29